Frederick Nguele Meke

Frederick Nguele Meke's research focuses on how certain enzymes called phosphatases (proteins that remove phosphate groups from other proteins) control cancer-related signaling pathways, particularly in blood cancers like leukemia and lymphoma. Recent work examines proteins such as PRL2 and SHP2, studying how blocking their activity affects tumor growth and other cellular processes like protein breakdown (autophagy). The lab also uses advanced imaging and mass spectrometry techniques to study protein forms within tissue samples.

Publication output was minimal or absent for most of the past decade but increased sharply starting in 2022, with a pronounced spike in 2024, suggesting a recent period of growing research activity.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026